Strategic partnerships Synapticure has a track record of securing strategic investors and corporate collaborators, including Biogen, CVS Health Ventures, RA Capital Management, CommonSpirit Health, and Nexus NeuroTech Ventures, indicating strong interest from large healthcare ecosystems that can open channel partnerships, referrals, and co-marketing opportunities.

Expansion into ataxia care Recent initiatives to offer remote neurological care for Friedreich's ataxia and other ataxias suggest a targeted entry point for specialized care programs, enabling cross-sell to caregivers and patients seeking niche neurology services augmented by virtual care.

Integrated care platform With a tech stack spanning Databricks, Power BI, and scalable languages, Synapticure positions itself as a data-enabled care navigation and tele-neurology platform, presenting upsell opportunities for partners requiring analytics, outcomes tracking, and population health management.

Marketing and awareness Partnerships with MyBrainGuide and large health systems imply alignment with patient education and disease awareness efforts, offering joint campaigns, patient onboarding funnels, and content-driven lead generation for neurology and dementia care services.

Funding and growth signals A recent $25M funding round led by major health-affiliated investors signals investor confidence and potential for growth-focused collaborations, enabling us to propose enterprise deals, managed services, and scalable virtual care solutions to large health networks.